Invention Grant
US07662579B2 Cytogenetically determined prognosis of myeloma 有权
细胞遗传学确定的骨髓瘤预后

Cytogenetically determined prognosis of myeloma
Abstract:
The invention provides methods and materials for determining a prognosis for myeloma and myeloma-disposed patients. The methods include the use of FISH techniques. The identification of the chromosomal abnormalities t(4;14)(p16;q32), t(14;16)(q32;q23), or 17p13 deletion (p53) in plasma cells from a patient indicates a poor prognosis.
Public/Granted literature
Information query
Patent Agency Ranking
0/0